NEW YORK, March 02, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against SITO Mobile, Ltd. (“SITO” or the “Company”) (NASDAQ:SITO) and certain of its officers, and is on behalf of purchasers of SITO securities between February 9, 2016, and January 2, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/sito.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) SITO’s development of bookings would not drive the Company’s fourth fiscal quarter 2016 media placement revenues and revenue growth to the level represented during the Class Period; (2) SITO was aware that the election would impact its fourth fiscal quarter 2016 revenue; (3) clients’ campaign spending and media placement revenues in the fourth quarter 2016 was highly dependent on the election; (4) SITO’s growth in media placement revenues would not occur in the fourth fiscal quarter 2016; (5) consequently, SITO’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
On January 3, 2017, SITO released discouraging quarterly revenue results for its preliminary media placement for the quarter ending December 31, 2016. SITO said its results were “negatively affected this year by restrained advertising spending during a period of heightened and elongated media focus on this year’s U.S. election.” Jerry Hug SITO’s CEO was quoted, “We clearly underestimated the effects of this year’s election on our clients’ campaign spending.” Despite a positive conference call in the third quarter where Hug told an analyst that there would not be a significant drop from the election, the discouraging results came shortly after the SITO’s repeated hype and positive forecast. Following this news, SITO stock dropped 32% on January 3, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/sito or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in SITO you have until April 18, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 



